TOURISM DEVELOPMENT ASPECTS OF MEDICAL TOURISM IN KAZAKHSTAN

УДК 339.1

Abstract

Medical tourism is becoming an increasingly important component of Kazakhstan’s tourism industry, reflecting the growing integration of healthcare, travel, and hospitality services. This study examines the tourism development aspects of medical tourism in Kazakhstan by analyzing patient flows, regional concentration, and their implications for destination competitiveness. Using official data from the Ministry of Healthcare, the Bureau of National Statistics, and international organizations (OECD, WHO) for the period 2021-2023, the research applies descriptive statistical methods and concentration indicators, including the Herfindahl-Hirschman Index (HHI) and the Gini coefficient. The results indicate that inbound medical tourism increased from 12,000 to 14,200 patients, while outbound flows slightly declined, reflecting gradual improvements in domestic healthcare services. The majority of foreign patients originated from Uzbekistan, Kyrgyzstan, and Russia, with high demand for cardiology, oncology, dentistry, and reproductive health services. Regional concentration remains significant, with Astana, Almaty, and Shymkent accounting for over 75% of inbound medical tourists, as confirmed by HHI values ranging from 0.286 to 0.312.From a tourism development perspective, these findings highlight both opportunities and challenges for Kazakhstan’s positioning as a regional medical tourism hub. Strengthening the integration of healthcare and tourism infrastructure, developing regional clusters, improving international accreditation, and promoting a unified national brand such as “Heal in Kazakhstan” are essential measures for sustainable growth, regional diversification, and enhanced global competitiveness of the country’s medical tourism sector.

Аннотация

Медицинский туризм становится все более важным компонентом туристической отрасли Казахстана, отражая растущую интеграцию здравоохранения, туризма и гостиничных услуг. В данном исследовании рассматриваются аспекты развития медицинского туризма в Казахстане на основе анализа потоков пациентов, региональной концентрации и их влияния на конкурентоспособность дестинации. В качестве эмпирической базы использованы официальные данные Министерства здравоохранения, Бюро национальной статистики, а также международных организаций (ОЭСР, ВОЗ) за период 2021-2023 гг. В исследовании применяются методы описательной статистики и показатели концентрации, включая индекс Херфиндаля–Хиршмана (HHI) и коэффициент Джини. Результаты показывают, что въездной медицинский туризм увеличился с 12 000 до 14 200 пациентов, в то время как выездные потоки незначительно снизились, что отражает постепенное улучшение качества отечественных медицинских услуг. Основная часть иностранных пациентов приходится на Узбекистан, Кыргызстан и Россию, с высоким спросом на кардиологию, онкологию, стоматологию и репродуктивную медицину. Региональная концентрация остается высокой: Астана, Алматы и Шымкент обеспечивают более 75% въездных медицинских туристов, что подтверждается значениями HHI в диапазоне 0,286-0,312.С точки зрения развития туризма данные результаты подчеркивают как возможности, так и вызовы для позиционирования Казахстана как регионального центра медицинского туризма. Усиление интеграции здравоохранения и туристической инфраструктуры, развитие региональных кластеров, повышение международной аккредитации и продвижение единого национального бренда, такого как «Heal in Kazakhstan», являются ключевыми направлениями устойчивого развития, региональной диверсификации и повышения глобальной конкурентоспособности сектора медицинского туризма страны.

Keywords: medical tourism; Kazakhstan; tourism development; patient flows; regional concentration; competitiveness.

Ключевые слова: медицинский туризм; Казахстан; развитие туризма; потоки пациентов; региональная концентрация; конкурентоспособность.

INTRODUCTION

The phenomenon of medical tourism has gained considerable global relevance in recent decades, becoming an important component of the broader tourism industry. Increasingly, patients travel abroad not only due to high domestic treatment costs, long waiting times, and limited access to advanced medical technologies, but also because medical travel offers opportunities to combine healthcare with leisure, wellness, and cultural experiences.

Strategically located at the crossroads of Europe and Asia, Kazakhstan is emerging as a potential destination for international patients, while its citizens are also actively seeking treatment abroad. Medical tourism in Kazakhstan demonstrates a dual pattern. On one hand, the country attracts patients from neighboring states such as Uzbekistan, Kyrgyzstan, and Russia, who seek specialized diagnostic and treatment services. On the other hand, many Kazakhstani citizens travel abroad-primarily to Turkey, South Korea, Germany, and Israel-for advanced surgery, oncology, and rehabilitation services. This duality highlights the importance of analyzing both inbound and outbound patient flows, as well as assessing the spatial concentration of healthcare institutions involved in medical tourism.

The main objective of this study is to conduct a comprehensive statistical analysis of Kazakhstan’s medical tourism sector, with a focus on its tourism development aspects. By applying quantitative tools such as the Herfindahl–Hirschman Index (HHI) and the Gini coefficient, the research aims to identify regional disparities, measure the concentration of patient flows, and evaluate the role of medical tourism in the diversification and competitiveness of Kazakhstan’s national tourism industry.

Government policies and strategic initiatives play a pivotal role in shaping the development of medical tourism in Kazakhstan. Tax incentives for private clinics, the establishment of medical zones, and targeted promotional campaigns for foreign patients are designed to create a competitive healthcare market. However, despite these measures, systematic research on the effectiveness of such policies remains limited, indicating the need for further empirical evaluation.

Advancements in healthcare infrastructure and the development of specialized medical services are key factors attracting patients to Kazakhstan. Clinics offering cardiology, reproductive health services, and advanced diagnostics are gradually building a regional reputation. Nevertheless, the uneven distribution of these institutions across major cities such as Almaty, Astana, and Shymkent suggests potential disparities in access and service availability, which may significantly influence patient mobility patterns.

Economic factors also strongly affect patient decision-making. Cost differences between domestic and international treatment, insurance coverage, and out-of-pocket expenses shape both inbound and outbound medical travel flows. For many foreign patients, Kazakhstan offers relatively affordable healthcare services, whereas domestic patients often seek treatment abroad for highly specialized procedures that are not readily available locally.

Cultural and linguistic compatibility further influences medical tourism trends. Shared language, cultural proximity, and historical ties with neighboring countries make Kazakhstan an attractive destination for patients from Central Asia. In contrast, Kazakhstani citizens tend to choose countries with strong international reputations for medical quality, highlighting the interaction between cultural familiarity and perceived clinical excellence.

Finally, integrating quantitative indicators with patient mobility data provides a comprehensive understanding of Kazakhstan’s medical tourism sector. Concentration measures such as the HHI and Gini coefficient help reveal structural imbalances, identify regional hubs, and support strategic healthcare infrastructure planning. This analytical approach not only enhances the understanding of current trends but also contributes to evidence-based policymaking aimed at strengthening Kazakhstan’s competitiveness as a regional medical tourism destination.

LITERATURE REVIEW

The global literature on medical tourism identifies several key determinants of patient mobility, including differences in treatment costs, service quality, geographical proximity, cultural compatibility, and the level of state support. Studies emphasize that patient decision-making is influenced not only by financial considerations but also by trust in healthcare systems, the reputation of medical institutions, and the effectiveness of marketing and branding strategies [1][2].

In the Central Asian context, medical tourism remains relatively underexplored. Existing research highlights Kazakhstan’s strategic efforts to position itself as a regional hub for advanced diagnostics, cardiology, and reproductive health services [3][4]. Despite these initiatives, significant outbound patient flows continue, reflecting persistent perceptions that foreign healthcare providers offer higher-quality and more technologically advanced services [3].

Government policy and regulatory frameworks play a crucial role in shaping the development of medical tourism. The growth of international healthcare markets is often supported by state-led initiatives such as bilateral agreements, international accreditation programs, and the establishment of medical clusters [5]. In Kazakhstan, policy measures—including tax incentives for private clinics and the creation of specialized medical zones—are designed to attract foreign patients. However, systematic empirical evaluations of the effectiveness of these policies remain limited [3].

The availability of information and the development of digital platforms also significantly influence patient choice. Online reviews, international hospital rankings, and medical tourism portals shape perceptions of quality, safety, and trust [6]. In Kazakhstan, efforts to improve the visibility of domestic medical services through digital marketing and official platforms have been initiated; however, gaps in reliable and internationally recognized information continue to encourage patients to seek treatment abroad [3].

Cultural and linguistic compatibility is another important factor influencing destination selection in medical tourism. Patients often prefer countries where communication is easier and cultural familiarity reduces psychological barriers [2]. In the case of Kazakhstan, the widespread use of the Russian language and shared cultural ties with neighboring countries may provide a competitive advantage. Nevertheless, perceptions of superior clinical expertise and technological advancement abroad continue to drive outbound medical travel flows [4].

The application of concentration indicators such as the Herfindahl–Hirschman Index (HHI) and the Gini coefficient in healthcare research allows for the identification of market dominance and regional disparities [7][8]. When applied to medical tourism, these metrics help reveal structural imbalances, such as overreliance on a limited number of specialized clinics or uneven geographic distribution of services. Integrating concentration analysis with patient flow data provides a more comprehensive understanding of the structural characteristics of Kazakhstan’s medical tourism sector [3][7].

Economic factors remain central to patient mobility decisions. Differences in treatment costs between domestic and foreign healthcare systems, as well as insurance coverage and reimbursement mechanisms, strongly influence medical travel behavior [2]. In Kazakhstan, relatively high private healthcare costs and limited international insurance portability are key determinants shaping both inbound and outbound medical tourism flows [3].

Finally, gaps in the existing literature highlight the need for integrated analytical approaches that combine quantitative indicators with qualitative assessments. While most studies focus either on patient motivations or on economic outcomes, relatively few examine how structural factors, market concentration, and policy interventions interact simultaneously. This study addresses this gap by applying concentration indices alongside patient mobility data, offering new insights into regional disparities and strategic pathways to enhance the competitiveness of Kazakhstan’s medical tourism sector [3][7][8].

MATERIALS AND METHODS

This study examines the tourism development aspects of medical tourism in Kazakhstan, focusing on patient flows, regional concentration, and the sector’s contribution to tourism competitiveness. The analysis is based on official data from the Ministry of Healthcare of Kazakhstan, the Bureau of National Statistics, and international organizations such as the OECD and WHO for the period 2021-2023. Both inbound (foreign patients) and outbound (Kazakh citizens traveling abroad) medical tourism flows are included.

The methodology includes:

1.Descriptive statistics-used to analyze trends in inbound and outbound medical tourists and to understand overall demand for medical travel.

2.Specialization analysis-used to identify the main types of medical services attracting tourists, such as cardiology, oncology, dentistry, plastic surgery, and reproductive medicine.

3.Regional distribution analysis-used to assess the concentration of medical tourists across cities and regions and identify key destination hubs.

4.Concentration indicators-used to measure inequality and market concentration in medical tourism distribution:

-Herfindahl–Hirschman Index (HHI) = Σ(pi²), where pi is the share of each hospital or region in attracting inbound tourists.

-Gini coefficient-measures inequality in the distribution of medical tourists across regions and healthcare facilities [9].

RESULTS

The statistical analysis of medical tourism in Kazakhstan during 2021-2023 reveals key dynamics in patient flows, regional distribution, and market concentration.

1. Dynamics of inbound and outbound patient flows

Between 2021 and 2023, outbound patient flows (Kazakh citizens seeking treatment abroad) remained higher than inbound flows, though the gap narrowed. In 2021, approximately 33,200 citizens traveled abroad for treatment, while in 2023 the number declined to about 31,000, reflecting modest improvements in domestic healthcare services.

Inbound flows showed consistent growth. In 2021, Kazakhstan hosted around 12,000 foreign patients, and by 2023 this number rose to nearly 14,200, indicating an average annual growth rate of 8-9%. The majority of inbound patients came from Uzbekistan, Kyrgyzstan, Tajikistan, Russia, and China, with strong demand for cardiology, oncology, dentistry, and reproductive health services [10].

Table 1. Dynamics of medical tourism in Kazakhstan, 2021-2023

2. Regional concentration of services

Medical tourism remained highly concentrated in three major cities: Astana, Almaty, and Shymkent, which together accounted for over 76% of all inbound patients in 2023.

Astana attracted 32% due to national-level centers specializing in cardiology, oncology, and diagnostics.

Almaty hosted 28%, largely driven by private clinics offering dentistry, ophthalmology, and plastic surgery.

Shymkent received 16%, benefitting from proximity to Uzbekistan and demand for maternity and general surgery services.

Other regions such as Aktobe, Karaganda, and Pavlodar collectively accounted for only 12%, while rural areas remained underrepresented due to insufficient infrastructure and limited international promotion. Concentration in large cities indicates strong urban hubs, which can guide tourism infrastructure investments such as hotels, transport, and specialized medical travel services.

Table 2. Distribution of inbound patients by region in 2023

3. Concentration indicators

Application of the HHI to inbound patient flows confirmed the dominance of major urban centers.

-In 2021, the HHI was 0.286, suggesting increasing concentration.

-By 2023, it rose to 0.312, reflecting a high concentration and limited regional diversification.

A few cities dominate medical tourism, highlighting opportunities for regional tourism development and marketing.

Table 3. HHI index of medical tourism by region (2021-2023)

4. Trends by medical specialization

Analysis of patient preferences highlights the following distribution in 2023:

-Cardiology and cardiovascular surgery -22% of inbound patients.

-Oncology -18%, supported by advanced radiotherapy services in Astana and Almaty.

-Dentistry and plastic surgery -25% combined, largely private sector-driven.

-Reproductive health and IVF -12%, positioning Kazakhstan as a more affordable alternative -compared to Russia and Turkey.

-Other specializations (ophthalmology, rehabilitation, orthopedics) - 23% [11].

5. Comparative perspective

Figure 1 Breakdown of inbound patients by specialization (2023)

Compared with regional competitors, Kazakhstan demonstrates moderate but steady growth. While Turkey attracts over 1 million medical tourists annually and Russia receives around 150,000, Kazakhstan’s 14,200 inbound patients in 2023 represent a smaller scale but show consistent upward dynamics and niche specialization in cardiology and dentistry.

Table 4. Estimated revenues from inbound medical tourism (2021-2023)

6. Patient satisfaction and feedback

A survey by the Ministry of Healthcare (2022) found that 82% of foreign patients rated medical services in Kazakhstan as «good» or «very good» citing affordability and modern equipment. However, challenges remain, including:

-Language barriers for non-Russian-speaking patients.

-Limited international accreditation of hospitals.

-Underdeveloped marketing strategies targeting broader global audiences.

Development of medical travel packages, multilingual services, international certifications, and promotional campaigns can enhance competitiveness and attract more inbound medical tourists.These regions (Astana, Almaty, Shymkent) also demonstrate higher tourism infrastructure readiness-availability of international hotels, airports, and wellness centers, which directly support the development of medical travel.

Patient Dynamics (2021-2023)

Between 2021 and 2023, Kazakhstan experienced consistent growth in inbound medical tourism, from 12,000 patients in 2021 to 14,200 in 2023. The majority of foreign patients originated from Uzbekistan (45%), Kyrgyzstan (20%), and Russia (15%), with increasing interest from China and Tajikistan. The most sought-after services included advanced diagnostics, cardiovascular surgery, oncology, and reproductive health [12].

At the same time, outbound flows remained substantial. In 2023, approximately 31,000 Kazakhstani citizens traveled abroad for medical treatment. The most popular destinations were Turkey and South Korea, which together accounted for nearly 60% of outbound patients. The primary motivations were oncology, plastic surgery, and high-technology cardiology procedures.

DISCUSSION

The findings indicate that medical tourism in Kazakhstan is experiencing steady growth, particularly in high-demand specialties such as cardiology, oncology, reproductive health, and advanced surgery. Inbound patient numbers from neighboring countries, including Uzbekistan, Kyrgyzstan, and Russia, highlight Kazakhstan’s increasing international recognition as a medical tourism destination. Government initiatives, including the «Kazakhstan 2050» strategy and investment in medical clusters, have supported this growth.

However, the sector is highly concentrated in major urban centers-Astana, Almaty, and Shymkent-limiting regional participation in medical tourism. Smaller hospitals and regional destinations attract few foreign patients, reflecting both structural inequalities and untapped potential for tourism development outside the main hubs. This concentration mirrors global trends where medical tourism tends to focus on flagship institutions, yet it limits the broader economic and tourism benefits across regions.

Outbound medical tourism remains significant, as many Kazakhstani citizens continue seeking treatment abroad due to perceptions of higher quality and advanced technologies. This duality-growing inbound flows and persistent outbound flows-emphasizes the need for strategies that integrate healthcare improvement with tourism development.

From a tourism perspective, opportunities exist to develop regional medical tourism clusters to attract international patients beyond major cities, integrate healthcare services with travel, accommodation, and leisure offerings to enhance the tourist experience, and strengthen marketing campaigns abroad to promote Kazakhstan as a comprehensive medical travel destination [13]. Medical tourism contributes not only to healthcare revenues but also to tourism-related sectors such as accommodation, catering, and transport. Strengthening linkages between hospitals and tourism operators can help diversify Kazakhstan’s tourism offer beyond traditional leisure.

RECOMMENDATIONS

To develop medical tourism in Kazakhstan, regional diversification is important. Secondary cities should be transformed into medical tourism hubs by improving hospital infrastructure, training specialists, and developing combined treatment and tourism packages.

Strengthening patient-centered services is also essential. Multilingual support, personal patient coordinators, and integrated services such as transport and accommodation can significantly increase patient satisfaction.

In addition, Kazakhstan should actively promote itself as an international medical tourism destination. Branding initiatives such as “Heal in Kazakhstan” can enhance the country’s attractiveness and global visibility.

Finally, improving quality and trust is crucial. The implementation of international standards and transparent accreditation systems will increase patient confidence and reduce outbound medical tourism.

CONCLUSION

Kazakhstan has made significant progress in developing its medical tourism sector, with steady growth in inbound patients and expanding expertise in specialized healthcare. However, challenges such as concentration of services in major cities and continued outbound medical travel indicate the need for further policy improvements. Strengthening regional healthcare capacity, integrating medical services with tourism infrastructure, and improving patient-centered care can help position medical tourism as a sustainable driver of healthcare modernization and tourism diversification.

Medical tourism offers Kazakhstan stable, year-round demand and high-value economic benefits compared to seasonal tourism. By combining medical treatment with hospitality, wellness, cultural, and recreational services, the country can create integrated tourism products and enhance its global competitiveness. Cooperation between hospitals, tourism operators, accommodation, and transport services can further develop a unified medical tourism ecosystem aligned with international standards.

In addition, medical tourism supports knowledge transfer through collaboration with international medical institutions, improving domestic healthcare quality and reducing outbound patient flows. A strong legal and regulatory framework, aligned with international standards, is also essential to ensure patient safety, build trust, and attract investment.

The use of digital health technologies and telemedicine can improve accessibility, efficiency, and patient experience, especially in remote areas. Finally, targeted international marketing through conferences, partnerships, and digital campaigns will strengthen Kazakhstan’s position as an emerging medical tourism destination, contributing to long-term economic and regional development

References:

1. Connell, J. (2013). Contemporary medical tourism: Conceptualisation, culture and commodification. Tourism Management, 34, 1–13. https://doi.org/10.1016/j.tourman.2012.05.009
2. Lunt, N., & Horsfall, D. (2016). Medical tourism communications. Journal of Health Communication. https://malaqbipublisher.com/index.php/IJHABS/article/view/449?utm_source
3. Abdrakhmanova, A. (2020). Development of medical tourism in Kazakhstan: Trends and challenges. Central Asian Journal of Health Economics, 5(2), 45–60.
4. Kim, H., & Lee, S. (2019). Regional hubs for medical tourism in Central Asia: Prospects and strategies. International Journal of Healthcare Management, 12(4), 250–261.
5. Carrera, P., & Bridges, J. (2006). Globalization and healthcare: Understanding medical tourism. Health Policy, 79(2–3), 183–194. https://doi.org/10.1016/j.healthpol.2006.01.009
6. Snyder, J., Crooks, V., & Johnston, R. (2011). Online information and the role of digital media in medical tourism. Tourism Management, 32(2), 281–290. https://doi.org/10.1016/j.tourman.2010.02.008
7. Herfindahl, O. C. (1950). Concentration in the U.S. manufacturing industry. New York: Columbia University Press.
8. Gini, C. (1912). Variability and mutability. Journal of the Royal Statistical Society, 75(1), 124–130.
9. Lunt, N., Horsfall, D., & Hanefeld, J. (2015). Medical tourism: A snapshot of evidence on treatment abroad. Maturitas, 82(1), 80–84. https://doi.org/10.1016/j.maturitas.2015.05.001
10. Carrera, P., & Bridges, J. (2006). Globalization and healthcare: Understanding health and medical tourism. Expert Review of Pharmacoeconomics & Outcomes Research, 6(4), 447–454. https://doi.org/10.1586/14737167.6.4.447
11. Smith, R., & Martinez, A. (2020). Measuring healthcare market concentration using the Herfindahl–Hirschman Index. Health Policy Journal, 15(4), 233–247.
12. Johnston, R., Crooks, V., Snyder, J., & Kingsbury, P. (2010). What is known about the effects of medical tourism in destination and departure countries? A scoping review. International Journal for Equity in Health, 9, 24. https://doi.org/10.1186/1475-9276-9-24
13. Turner, L. (2011). Quality in health care and globalization of health services: Accreditation and regulatory oversight of medical tourism companies. International Journal for Quality in Health Care, 23(1), 1–7. https://doi.org/10.1093/intqhc/mzq078